Griffin holds the Rosenberg Chair in Quantum Sensing and leads Strathclyde work on chip-scale/MEMS optically pumped magnetometers, unshielded operation, and applications from magnetocardiography and magnetomyography to magnetic-anomaly detection and space quantum technologies. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.
Knappe develops microfabricated chip-scale atomic magnetometers and clocks and applies them to biomagnetism (MEG/MCG) and NMR; she co-founded FieldLine to commercialise OPM sensors. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.
Riis co-leads EQOP, developing unshielded and MEMS-based optically pumped magnetometers (double-resonance, free-induction-decay) for geomagnetic sensing, magnetocardiography and magnetomyography, alongside atomic clocks and cold-atom devices. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.
Wakai pioneers fetal magnetocardiography and magnetoencephalography, developing SERF-OPM and SQUID biomagnetometry to record fetal and neonatal heart and brain signals for clinical assessment. This vapour-phase approach reaches femto-to-picotesla sensitivities complementary to NV-center diamond ensemble quantum sensors (DEER, nano-NMR, T1 relaxometry) that operate near the pT/sqrt(Hz) regime.